Diana Roettger, PhD, and Olga Kubassova, PhD[email protected]MRIAdvanced imaging offers insight into targeted therapiesMajor breakthroughs are emerging in the development of targeted therapies that use the body's own immune system to attack cancer cells. But traditional methods of measuring the success of drug candidates are slow and expensive. Could advanced imaging help? Diana Roettger, PhD, and Olga Kubassova, PhD, of the Image Analysis Group offer a perspective.February 5, 2019Page 1 of 1Top StoriesCTPET/CT identifies bone demineralization in breast cancer patientsPET/CT holds promise as an opportunistic osteoporosis screening tool in high-risk oncology subgroups.MRIIs MRI in patients with retained metal fragments dangerous?Womens ImagingAI shows promise as second reader in breast cancer screeningResidents/FellowsRad residents show interest in global health imaging, but face barriersAIInvestigators test ChatGPT-4 Turbo for radiology AI monitoring
